Genexa
Signal active
Organization
Contact Information
Overview
Genexa develops medicines with cleaner inactive ingredients intended to make medicine healthier. They create organic, non-GMO medicines to treat target colds, sleep, stress relief, colds, and allergies, enabling consumers to stay fit and healthier.
About
Industries
Pharmaceutical, Medical, Manufacturing
Founded
2016
Employees
11-50
Headquarters locations
United States, North America
Social
N/A
Profile Resume
Genexa headquartered in United States, North America, operates in the Pharmaceutical, Medical, Manufacturing sector. The company focuses on Pharmaceutical and has secured $720.0M in funding across 12 round(s). With a team of 11-50 employees, Genexa is actively contributing to advancements in Pharmaceutical. Their latest funding round, Series A - Genexa, raised $60.0M. Discover more about their projects, partnerships, and impact on our platform.
Funding Rounds
Funding rounds
1
Investors
23
Lead Investors
0
Total Funding Amount
$60.0M
Details
1
Genexa has raised a total of $60.0M in funding over 1 rounds.
| Announcement date | Transaction name | Number of Investors | Money raised | Lead Investor |
|---|---|---|---|---|
| 2021 | Early Stage Venture | 60.0M |
Investors
Genexa is funded by 25 investors.
| Investor Name | Lead Investor | Funding Round | Partners |
|---|---|---|---|
| Brandon Shainfeld | - | FUNDING ROUND - Brandon Shainfeld | 60.0M |
| Jennifer Meyer | - | FUNDING ROUND - Jennifer Meyer | 60.0M |
| Genexa | - | FUNDING ROUND - Genexa | 60.0M |
| Bill Silva Ventures | - | FUNDING ROUND - Bill Silva Ventures | 60.0M |
Recent Activity
There is no recent news or activity for this profile.